지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Role of neoadjuvant treatment for resectable pancreatic ductal adenocarcinoma
한국간담췌외과학회 학술대회지
2017 .03
The Role of Neoadjuvant Treatment in Resectable Pancreatic Cancer
대한외과학회 학술대회 초록집
2019 .10
Clinical Outcomes of the Borderline Resectable Pancreatic Cancer according to the Neoadjuvant Chemo-Regimens: Gemcitabine vs. FOLFIRINOX
대한외과학회 학술대회 초록집
2019 .10
Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
Gut and Liver
2022 .01
Current status of neoadjuvant therapy for pancreas cancer
대한임상종양학회 학술대회지
2021 .06
Great Debates: Which is the Best? Resectable pancreatic cancer: Neoadjuvant treatment first
대한임상종양학회 학술대회지
2019 .02
Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .05
Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOX
Gut and Liver
2021 .01
Survival improvement in locally advanced pancreatic cancer after FOLFIRINOX neoadjuvant treatment and conversion surgery
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Does Current Staging System Applicable for Borderline Resectable or Locally Advanced Pancreatic Cancer after Neoadjuvant Chemotherapy?
대한외과학회 학술대회 초록집
2022 .05
Updates of Chemotherapy and Radiotherapy for Pancreatic Cancer
대한췌담도학회지
2020 .01
The change of clinical stage after neoadjuvant chemotherapy in prediction of prognosis for borderline resectable and locally advanced pancreatic cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Corrigendum to: Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
Gut and Liver
2023 .03
Metastatic Pancreatic Carcinoma and Experience with FOLFIRINOX - a Cross Sectional Analysis From a Developing Country
Asian Pacific journal of cancer prevention : APJCP
2015 .01
Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX
Gut and Liver
2021 .01
Evaluation of the effect of neoadjuvant treatment in pancreatic ductal adenocarcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Comments on - Neoadjuvant Chemo-radiation with IMRT in Resectable and Borderline Resectable Pancreatic Cancer
Asian Pacific journal of cancer prevention : APJCP
2015 .01
Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2019 .05
Complete response of locally advanced left-sided pancreatic cancer after modified FOLFIRINOX chemotherapy followed by conversion surgery: A case report
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .08
The decrease or normalization of carbohydrate antigen 19-9 have comparable prognostic performance in patients with borderline resectable and locally advanced pancreatic cancer after neoadjuvant chemotherapy
대한외과학회 학술대회 초록집
2019 .10
0